MarketPulse

Chief Medical Officer appointment

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Jade Biosciences Names Chief Medical Officer, Awards $12.7M Stock Option Grant

Clinical-stage biotech Jade Biosciences appoints Dr. Edward Conner as CMO, grants 500,000 stock options valued at $12.7M as inducement under Nasdaq rules.
JBIOautoimmune diseasesclinical-stage biotechnology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sagimet Biosciences Names Veteran Pharma Executive Andreas Grauer as CMO

Sagimet Biosciences appoints Dr. Andreas Grauer as Chief Medical Officer, replacing retiring Dr. Eduardo Martins. Grauer joins from senior roles at Amgen and Corcept, receiving $1.34M in stock options.
AMGNSGMTOMERexecutive leadershipstock option grant
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Absci Bolsters Clinical Expertise with Vertex Pharma Veteran as New CMO

Absci appoints Vertex Pharma veteran Dr. Ransi Somaratne as Chief Medical Officer to lead clinical development of AI-designed therapeutics, signaling execution focus.
VRTXABSIclinical developmentVertex Pharmaceuticals